Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03087396 · ClinicalTrials.gov registry record
A Longitudinal Outcomes Study of the Subchondroplasty® Procedure in the Foot/Ankle
A clinical trial, sponsored by Zimmer Biomet.
- Completed
- Registry status
- 148
- Enrollment target
NCT03087396: Completed study, sponsored by Zimmer Biomet.
NCT03087396 is a clinical trial that has completed, run by Zimmer Biomet. The registered enrollment target is 148 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03087396 has completed, sponsored by Zimmer Biomet.
- COMPLETED
- Registry status
- 148 participants
- Enrollment target
Study Summary
Post Market clinical outcomes study to collect data on the short - and long-term outcomes for subjects who are undergoing or who have undergone the Subchondroplasty Procedure in the foot and/or ankle in a standard clinical setting. Outcomes to be assessed include pain medication usage, pain, function, activity levels and patient satisfaction.
Primary Outcome
Foot Function Index - Revised Short Form (FFI-R SF) subscale scores. Measures foot pain, disability, and activity limitation. Items scored 1-4 (1=best, 4=worst); 5=not applicable to the subject and does not indicate worse function. Subscales calculated from applicable items and converted to 0-100%. Higher=more pain/worse function.
Interventions
- DEVICE Treatment of insufficiency fractures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2017-03-10 |
| Est. Completion | 2023-08-23 |
What the finished NCT03087396 record still lists
NCT03087396 is an observational study that tracks outcomes without assigning an intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Treatment of insufficiency fractures is the first listed.
NCT03087396 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03087396 about?
NCT03087396 is a clinical study titled "A Longitudinal Outcomes Study of the Subchondroplasty® Procedure in the Foot/Ankle". Post Market clinical outcomes study to collect data on the short - and long-term outcomes for subjects who are undergoing or who have undergone the Subchondroplasty Procedure in the foot and/or ankle in a standard clinical setting. Outcomes to be assessed include pain medication usage, pain, functio...
What is the current status of trial NCT03087396?
This trial is currently completed. The enrollment target is 148 participants. The study started on 2017-03-10. Estimated completion is 2023-08-23.
What interventions are being tested in trial NCT03087396?
The interventions under investigation include: Treatment of insufficiency fractures (DEVICE).
Who is sponsoring clinical trial NCT03087396?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00739362 · 148 participants · Phase 2
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
- NCT03161223 · 148 participants · Phase 1
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
- NCT03858231 · 148 participants · Phase 4
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
- NCT04486352 · 148 participants · Phase 1
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI